Related Experiment Video
Updated: Aug 8, 2026
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
[Labyrinth involvement in Langerhan's cell histiocytosis]
Insights
Langerhans cell histiocytosis, a rare condition, involves abnormal cell growth affecting the temporal bone, primarily the middle ear and mastoid. Early diagnosis and treatment are crucial to prevent irreversible hearing loss.
Area of Science:
- Pathology
- Otolaryngology
- Histiocytosis
Background:
- Langerhans' cell histiocytosis (LCH) is a rare disorder characterized by abnormal proliferation of Langerhans cells.
- This condition can infiltrate various body structures, with a significant predilection for the temporal bone.
Observation:
- Involvement of the middle ear and mastoid is common in temporal bone LCH, reported in 61% of cases.
- The inner ear is less frequently affected but is more susceptible to irreversible damage.
Findings:
- Granulation tissue in LCH can lead to destructive lesions within the temporal bone.
- Neurosensorial hearing loss is a potential consequence of inner ear involvement.
Implications:
- Prompt diagnosis of LCH affecting the temporal bone is critical.
- Strategic therapeutic sequencing is essential to mitigate the risk of permanent hearing impairment.
Abstract:
Langerhans' cell histiocytosis is a rare pathology that implies an abnormal proliferation of these kind of cells associated with granular infiltration that affects different structures of the human body, including the temporal bone. The middle ear and the mastoid are mostly involved (61%). The inner ear is more resistant to the destruction caused by the granulation tissue, but when occurs, an irreversible neurosensorial hearing loss appears. The early diagnose and the choice of the therapeutical sequences are essential to avoid these lesions.
